Skip to content
Buchalter
  • About
  • Careers
  • Diversity
  • Contact
  • Offices
  • Attorneys
  • Practices & Industries
  • Thought Leadership
    • Publications
      • Chemical Law & Prop 65 Blog
    • Webinars
    • Videos
    • Podcasts
  • News & Events
    • News
    • Events/
      Speaking Engagements
  • Payment Portal
    • Pay your invoice
    • Pay your retainer
  • Attorneys
  • Practices & Industries
  • Thought Leadership +
    • Videos
    • Podcasts
    • Publications
    • Chemical Law & Prop 65 Blog
    • Webinars
  • News & Events +
    • News
    • Events/
      Speaking Engagements
  • About
  • Careers
  • Diversity
  • Contact
  • Offices
  • Payment Portal +
    • Pay your invoice
    • Pay your retainer
« View All News

Buchalter Welcomes Two New Shareholders in Los Angeles

LOS ANGELES, Calif., August 7, 2018 – Buchalter is pleased to announce that both Peter V. Hogan and Dennis E. Raglin have joined the firm as Shareholders in the Los Angeles office.

Mr. Hogan, a member of the Corporate Practice Group, represents middle market and emerging growth companies in initial public offerings, second offerings, mergers and acquisitions, angel and venture capital financing, 1934 Act reporting obligations, as well as the interests of broker-dealers.

As a member of the Litigation Practice Group, Dennis Raglin has over 20 years of experience as a litigator and concentrates his practice on defending clients in the areas of products liability, including medical device and pharmaceuticals, and in all types of general and complex litigation.  He also counsels and defends clients in California’s Proposition 65 right-to-know chemical warnings law, as well as state and national chemical compliance laws and regulations generally.

“I am so pleased to welcome Peter and Dennis, said President and Chief Executive Officer Adam J. Bass.  “They are both accomplished attorneys who bring a wealth of knowledge and expertise to our transactional and litigation practices.”

Mr. Hogan’s clients include private early stage, middle market, and publicly traded companies from the entertainment, digital media, manufacturing, restaurant, technology industries, software, payment processing and esports. He also advises companies on corporate governance, executive employment and shareholder matters.  Mr. Hogan received his J.D., from Boston College School of Law. He also earned his M.B.A. and B.A. from Boston College.

“I am thrilled to join Buchalter’s full-service Corporate Practice Group. The firm’s impressive platform allows me to offer unparalleled service to my clients and grow my practice,” said Peter Hogan.

Mr. Raglin’s clients span a wide range of industries, including representing clients who manufacture and distribute products that include implantable and prescription medical devices, prescription and over-the-counter pharmaceuticals, biologics, baby and toddler formula, nutritional supplements and food products, durable medical equipment, heavy equipment, automobiles, personal care goods and cosmetics, pet care products, household goods, sporting goods and water gear.  He earned his J.D. from the University of California, Davis School of Law and his B.A., cum laude, from the University of California, Riverside.

“My practice fits perfectly with Buchalter’s talented and growing litigation practice and I am excited to be joining the firm.  I look forward to integrating my clients and introducing them to the firm’s impressive capabilities,” added Raglin.

Media Mentions

  • Bloomberg Law
  • Daily Journal
  • General Counsel
  • Law360
  • NorthernCaliforniaRecord
  • The Recorder
Share

Related Attorneys

  • Peter V. Hogan

Adam Bass, Buchalter President & CEO

  • About
  • Careers
  • News & Events
  • Subscribe
  • Atlanta
  • Chicago
  • Denver
  • Los Angeles
  • Napa Valley
  • Nashville
  • Orange County
  • Portland
  • Sacramento
  • Salt Lake City
  • San Diego
  • San Francisco
  • Scottsdale
  • Seattle
  • © Copyright 2025 Buchalter, A Professional Corporation
  • Privacy Notice
  • Notice at Collection
  • Do Not Sell or Share PI
  • Tenrec Logo